Literature DB >> 23946455

A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody.

Hyunwook Lee1, Javier O Cifuente, Robert E Ashley, James F Conway, Alexander M Makhov, Yoshio Tano, Hiroyuki Shimizu, Yorihiro Nishimura, Susan Hafenstein.   

Abstract

Enterovirus 71 (EV71) is a picornavirus that causes outbreaks of hand, foot, and mouth disease (HFMD), primarily in the Asia-Pacific area. Unlike coxsackievirus A16, which also causes HFMD, EV71 induces severe neuropathology leading to high fatalities, especially among children under the age of 6 years. Currently, no established vaccines or treatments are available against EV71 infection. The monoclonal antibody MA28-7 neutralizes only specific strains of EV71 that have a conserved glycine at amino acid VP1-145, a surface-exposed residue that maps to the 5-fold vertex and that has been implicated in receptor binding. The cryo-electron microscopy structure of a complex between EV71 and the Fab fragment of MA28-7 shows that only one Fab fragment occupies each 5-fold vertex. A positively charged patch, which has also been implicated in receptor binding, lies within the Fab footprint. We identify the strain-specific epitope of EV71 and discuss the possible neutralization mechanisms of the antibody.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23946455      PMCID: PMC3807339          DOI: 10.1128/JVI.01926-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement.

Authors:  Sheng-Wen Huang; Ya-Fang Wang; Chun-Keung Yu; Ih-Jen Su; Jen-Ren Wang
Journal:  Virology       Date:  2011-11-09       Impact factor: 3.616

Review 2.  An overview of the evolution of enterovirus 71 and its clinical and public health significance.

Authors:  Peter C McMinn
Journal:  FEMS Microbiol Rev       Date:  2002-03       Impact factor: 16.408

Review 3.  Virology, epidemiology, pathogenesis, and control of enterovirus 71.

Authors:  Tom Solomon; Penny Lewthwaite; David Perera; Mary Jane Cardosa; Peter McMinn; Mong How Ooi
Journal:  Lancet Infect Dis       Date:  2010-10-18       Impact factor: 25.071

4.  Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection.

Authors:  Seiya Yamayoshi; Satoshi Koike
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

5.  Identification and characterization of a cross-neutralization epitope of Enterovirus 71.

Authors:  Chia-Chyi Liu; Ai-Hsiang Chou; Shu-Pei Lien; Hsiao-Yu Lin; Shih-Jen Liu; Jui-Yuan Chang; Meng-Shin Guo; Yen-Hung Chow; Wun-Syue Yang; Kate Hsuen-Wen Chang; Charles Sia; Pele Chong
Journal:  Vaccine       Date:  2011-04-16       Impact factor: 3.641

6.  Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene.

Authors:  Kok Keng Tee; Tommy Tsan-Yuk Lam; Yoke Fun Chan; Jon M Bible; Adeeba Kamarulzaman; C Y William Tong; Yutaka Takebe; Oliver G Pybus
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 7.  Clinical features, diagnosis, and management of enterovirus 71.

Authors:  Mong How Ooi; See Chang Wong; Penny Lewthwaite; Mary Jane Cardosa; Tom Solomon
Journal:  Lancet Neurol       Date:  2010-11       Impact factor: 44.182

8.  Molecular analysis of virulent determinants of enterovirus 71.

Authors:  Renqing Li; Qinghua Zou; Lijuan Chen; Herun Zhang; Yumei Wang
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

9.  Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.

Authors:  Xiao Fang Lim; Qiang Jia; Wei Xin Khong; Benedict Yan; Balraj Premanand; Sylvie Alonso; Vincent T K Chow; Jimmy Kwang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

10.  A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71.

Authors:  Xiangxi Wang; Wei Peng; Jingshan Ren; Zhongyu Hu; Jiwei Xu; Zhiyong Lou; Xumei Li; Weidong Yin; Xinliang Shen; Claudine Porta; Thomas S Walter; Gwyndaf Evans; Danny Axford; Robin Owen; David J Rowlands; Junzhi Wang; David I Stuart; Elizabeth E Fry; Zihe Rao
Journal:  Nat Struct Mol Biol       Date:  2012-03-04       Impact factor: 15.369

View more
  34 in total

1.  Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.

Authors:  Ke Lyu; Ya-Ling He; Hao-Yang Li; Rong Chen
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

2.  Human enterovirus 71 uncoating captured at atomic resolution.

Authors:  Ke Lyu; Jie Ding; Jian-Feng Han; Yu Zhang; Xiao-Yan Wu; Ya-Ling He; Cheng-Feng Qin; Rong Chen
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  Modeling the Role of Epitope Arrangement on Antibody Binding Stoichiometry in Flaviviruses.

Authors:  Daniel R Ripoll; Ilja Khavrutskii; Anders Wallqvist; Sidhartha Chaudhury
Journal:  Biophys J       Date:  2016-10-18       Impact factor: 4.033

4.  Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16.

Authors:  Maozhou He; Longfa Xu; Qingbing Zheng; Rui Zhu; Zhichao Yin; Zhenghui Zha; Yu Lin; Lisheng Yang; Yang Huang; Xiangzhong Ye; Shuxuan Li; Wangheng Hou; Yangtao Wu; Jinle Han; Dongxiao Liu; Zekai Li; Zhenqin Chen; Hai Yu; Yuqiong Que; Yingbin Wang; Xiaodong Yan; Jun Zhang; Ying Gu; Z Hong Zhou; Tong Cheng; Shaowei Li; Ningshao Xia
Journal:  Cell Host Microbe       Date:  2020-02-05       Impact factor: 21.023

5.  In Vitro and In Vivo Inhibition of the Infectivity of Human Enterovirus 71 by a Sulfonated Food Azo Dye, Brilliant Black BN.

Authors:  Tao Meng; Qiang Jia; Sek-Man Wong; Kaw-Bing Chua
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  The enterovirus 71 procapsid binds neutralizing antibodies and rescues virus infection in vitro.

Authors:  Kristin L Shingler; Javier O Cifuente; Robert E Ashley; Alexander M Makhov; James F Conway; Susan Hafenstein
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

7.  The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.

Authors:  Qunying Mao; Yiping Wang; Jie Shao; Zhifang Ying; Fan Gao; Xin Yao; Changgui Li; Qiang Ye; Miao Xu; Rongcheng Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015-02-25       Impact factor: 3.452

8.  Structural Basis of Human Parechovirus Neutralization by Human Monoclonal Antibodies.

Authors:  Shabih Shakeel; Brenda M Westerhuis; Ari Ora; Gerrit Koen; Arjen Q Bakker; Yvonne Claassen; Koen Wagner; Tim Beaumont; Katja C Wolthers; Sarah J Butcher
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

9.  Antiviral Activity of a Llama-Derived Single-Domain Antibody against Enterovirus A71.

Authors:  Peng-Nien Huang; Hsiang-Ching Wang; Hui-Chen Hung; Sung-Nien Tseng; Teng-Yuan Chang; Min-Yuan Chou; Yu-Jen Chen; Yun-Ming Wang; Shin-Ru Shih; John Tsu-An Hsu
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

10.  Characterization of the antibody response against EV71 capsid proteins in Chinese individuals by NEIBM-ELISA.

Authors:  Yingying Ding; Xuguang Chen; Baohua Qian; Guorong Wu; Ting He; Jiaojiao Feng; Caixia Gao; Lili Wang; Jinhong Wang; Xiangyu Li; Mingmei Cao; Heng Peng; Chunyan Zhao; Wei Pan
Journal:  Sci Rep       Date:  2015-05-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.